Iomeron (Iomeprol)

Iomeprol contains iodine atoms that strongly absorb X‑ray photons. After intravenous or intra‑arterial injection, the iodine‑rich solution circulates in the bloodstream, increasing the radiodensity of vascular structures and perfused tissues, which creates a contrast difference on X‑ray‑based imaging studies.

The dose of Iomeron is determined by the prescribing physician based on the specific imaging study, patient weight, renal function, and clinical protocol. Healthcare professionals calculate the appropriate volume and concentration for each individual case.

The safety of Iomeron in pregnancy and lactation has not been fully established. It should be used only if the potential diagnostic benefit outweighs any possible risk to the fetus or infant, and the decision should be made by the treating physician.

To order Iomeron, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Iomeron (Iomeprol) is a low‑osmolality, non‑ionic iodinated contrast medium, offering a favorable safety profile compared with high‑osmolality agents. It provides comparable image quality while reducing the incidence of discomfort and adverse reactions seen with older, ionic contrast media.

Iomeron should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the solution from moisture, direct sunlight, and extreme temperatures. Do not freeze or shake the vial before use.

Iomeron is administered as a sterile solution for injection via the intravenous or intra‑arterial route. The injection is performed by qualified healthcare personnel, typically using a power injector or manual bolus, following the imaging protocol prescribed for the specific diagnostic procedure.

Serious risks include severe allergic reactions (anaphylactoid response), contrast‑induced nephropathy leading to acute kidney injury, significant hypotension, cardiac arrhythmias, and neurologic events such as seizures. Immediate medical attention is required if any of these reactions occur.

Iomeron should be avoided in patients with a known severe allergy to iodinated contrast media, uncontrolled asthma, or severe renal impairment (eGFR < 30 mL/min/1.73 m²) unless the diagnostic benefit justifies the risk. It is also contraindicated in patients who have had a prior anaphylactic reaction to a similar agent.